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Spurred by the appreciation that protein aggregation, leading to amyloid fibril formation, is
linked to a growing list of diseases there has been intense effort to understand the factors that
trigger association between peptides. This vastly complex field has attracted a variety of ap-
proaches ranging from mutational studies at the genetic level to characterization of events at the
molecular level of specific proteins. It is unclear if biophysical approaches used to study protein
folding in quantitative terms will have a major impact on leading to a cure or management of
any amyloid disease, including Alzheimer’s Disease (AD). Nevertheless, it is clear that rigorous
biophysical methods are needed to gain a deeper understanding of the routes to amyloid for-
mation. After nearly fifteen years of in vitro experimentation and simulations, certain general
principles that govern oligomer (suspected to be the cause of toxicity) and amyloid formation
have emerged. A few of the most important findings are: (1) All proteins, regardless of whether
their aggregation is related to any specific disease, can form amyloid fibrils with characteristic
cross β structure [1]. This finding implies that under suitable conditions favoring aggregation
the folded monomeric state is unlikely to be the most stable. Although the possibility that folded
proteins are metastable was suggested long ago [2], only recently it has been argued that under
nominal protein concentrations found in cells the native state is metastable with respect to the
fibril state [3]. (2) The propensity of a polypeptide chain to aggregate is encoded in the the free
energies of the spectrum of states of the monomer [4]. There is a direct correlation between the
probability of accessing such aggregation-prone states and the rate of amyloid formation [5]. (3)
Although there are exceptions, solid state NMR experiments [6] on a number of systems, show
that in the amyloid fibril state the polypeptide chains are arranged as parallel β-sheets, which
given the conclusion summarized in (1) implies that the ground state of interacting peptides
has universal structural features. (4) Despite the possible universal structure of the fibrils, pre-
cise sequence plays a major role in the rate of protein aggregation as well as in the stability of
the final product [7]. Dramatic variations in aggregation rates of mutants of Aβ peptides [8],
implicated in AD, validates the importance of sequence.
The general principles that have been discovered, using well-defined systems summarized
above are of great significance, and establish the power of biophysical methods. However, the
studies leading to these conclusions do not even approximately model the process of in vivo
aggregation. For example, it is well-known that in order to understand amyloid formation in
vivo it is important to consider interactions of aggregating proteins with membranes, which in
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the biophysics community has received little attention. In the interesting Perspective appearing
in this issue Bucciantini et. al. [9] review the specific roles that membranes play in promoting
oligomer formation in amyloidogenic proteins with special emphasis on Aβ peptides. The authors
have managed to navigate a substantial portion of the still growing literature to summarize
the key membrane characteristics, which are involved in promoting or suppressing oligomer
formation. Based on general considerations it is clear that membrane-mediated aggregation
should depend on physical properties, such as net charge per unit area and hydrophobicity and
hydrophilicity. Indeed, it has been found that membranes composed of anionic phospholipids
(such as phosphatidylserine and phosphatidyglycerol) catalyze the formation of amyloids [10].
The mechanical properties of the fluid membranes also affect interaction between proteins, as
demonstrated using continuum theories. Thus, cholesterol (Ch) or crowding agents that effect
the overall membrane fluidity also affects aggregation [11], as summarized succinctly by [9]. It
is likely that theoretical ideas in the soft matter field could be profitably used to predict generic
aspects of membrane-mediated interpeptide interaction.
The specific details of membrane composition, which cannot be easily taken into account using
using only the general physicochemical properties, requires a deeper understanding of biological
membranes. For example, biological membranes form lipid rafts, which are best pictured as
heterogeneous structures. In rafts in neuronal cells, GM1 (see Fig. 2 in [9]) is the most abundant
ganglioside, and is implicated in AD, Parkinson, and Huntington diseases. Interaction of GM1
with Aβ might be involved in promoting Aβ aggregation. Further complicating matters, Ch,
whose role in affecting protein aggregation is not fully understood, appears to encourage the
formation of islands that are rich in GM1, reminiscent of microphase separation. Based on a
study of several model systems [12], it has been asserted that in a lipid mixture composition
resembling that found in the cerebral cortex, Aβ peptides were rapidly released resulting in
amyloid fibril formation. However, in membranes devoid of Ch and GM1, aggregation did
not occur, suggesting that both Ch and GM1 control Aβ aggregation in neuronal cells. In
an insightful study, it has been shown that the Ch effect depends roughly on λ = [Ch]/[Pl],
where [Ch]([PL]) is the concentration of Ch (phospholipids). At low λ values Aβ aggregation is
promoted whereas at higher values there is increased insertion of Aβ into the membranes, which
suppresses aggregation. Therefore, it is important to examine the phase diagram of the ternary
(minimum) of Ch, lipids, and Aβ before any general conclusion can be drawn. It is worth
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emphasizing that lipid composition, which greatly complicates the picture, is an important
variable. Because of this model membrane systems are extremely useful in obtaining insights
into the aggregation process.
A critical factor that is receiving increasing attention is the determination of the structures
and dynamics of the type I transmembrane Amyloid Precursor Protein (APP) found in neural
and non-neural cells. The cleavage of APP resulting in Aβ-peptide of varying lengths is achieved
by secretases [13]. Cleavage occurs in several steps. β-secretase cleaves APP at the β-site,
and the extracellular domain of APP disassociates from the remaining protein (APP-C99).
Subsequently, γ-secretase cleaves processively with normal termination at the γ-site, which is
located on the transmembrane domain of APP-C99, and the product Aβ-protein is released to
the extracellular region (Fig. 1). Many of the familial AD-associated mutations occur close to the
secretase cleavage sites (Fig. 1) and, intriguingly, their is evidence that mutations intermediate
to the β- and γ-sites may also influence the Aβ product distribution. A major focus of current
research on AD is to understand the elementary steps in the cleavage process, with the hope
that the design of drugs that modulate the production of deleterious Aβ products requires a
molecular description of the structures of APP-C99 in the presence of membranes. Simulations
as well as experiments have firmly established that the flexibility of the GG kink [14, 15] near
the γ-site plays an important role in the production of distinct isoforms of Aβ upon cleavage of
APP-C99 by γ-secretase. It is clear that a global understanding of AD (and related diseases)
can only be achieved through knowledge of the molecular structures of APP-C99, the details
of the cleavage processes by secretases, and characterization of subsequent events leading to
aggregation. All of these events involved in AD depend on lipid composition, Ch, and other
factors, thus making the biophysics of AD an extraordinarily rich field, which is sure to attract
physics-based approaches for years to come.
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FIG. 1: Schematic picture of the Amyloid Precursor Protein in a membrane. On the left the sequence
of a portion of APP is shown along with the sites for engaging the secretases. Cleavage by the flexible
GG kink in the inserted portion of APP near the γ-site produces Aβ peptides with 39 - 43 amino acid
residues. On the right a picture of the neuron and the way that APP interacts with the membrane of
the neuron cell is shown along with the different secretases.
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